Ectopic ATP synthase blockade suppresses lung adenocarcinoma growth by activating the unfolded protein response

Hsin-Yi Chang1, Hsuan-Cheng Huang, Tsui-Chin Huang

  • 1Institute of Molecular and Cellular Biology, Department of Life Science, Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.

Cancer Research
|July 24, 2012
PubMed

Insights

Ectopic ATP synthase on lung cancer cell membranes drives proliferation. Inhibiting it halts growth by triggering unfolded protein response (UPR) and reactive oxygen species (ROS), offering a potential therapeutic strategy.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Cellular Biology

Background:

  • Mitochondrial F(1)F(0)-ATP synthase is ectopically expressed on the plasma membrane in cancer.
  • The functional role of this plasma membrane ATP synthase in cancer remains largely undefined.

Purpose of the Study:

  • To investigate the functional role of ectopic plasma membrane ATP synthase in lung adenocarcinoma.
  • To explore the therapeutic potential of inhibiting this enzyme in lung cancer.

Main Methods:

  • Utilized ATP synthase inhibitor citreoviridin to study lung adenocarcinoma cells.
  • Analyzed protein expression profiles and employed siRNA to modulate specific pathways.
  • Assessed cell cycle, proliferation, and anchorage-independent growth.

Main Results:

  • Ectopic ATP synthase and electron transport chain on lung cancer cell plasma membranes support proliferation.
  • Citreoviridin treatment induced cell cycle arrest, inhibited proliferation, and anchorage-independent growth.
  • Inhibition triggered the unfolded protein response (UPR) via PERK, leading to eIF2α phosphorylation and growth arrest, amplified by ROS.

Conclusions:

  • Ectopic plasma membrane ATP synthase has a critical function in lung adenocarcinoma cell proliferation.
  • A positive feedback loop between UPR and ROS converges to block proliferation.
  • Targeting plasma membrane ATP synthase represents a potential therapeutic strategy for lung cancer.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...